A look at some of the exciting drugs that could be approved in the coming months.
They say the only certainties in life are death and taxes. Perhaps one of the greatest uncertainties is the drug pipeline-though there are many drugs in the pipeline at any one time, drugs that actually make it all the way through to market are rare.To help make sense of what to look forward to in the pipeline-what’s exciting, what’s not, what might actually be coming out, OptumRx analyzed the Q3 pipeline in their OptumRx Drug Pipeline Insights Report. They identified five drugs they expect the FDA to review and approve in coming months that could make the biggest impact on the market, looking at clinical quality, effectiveness, and cost.
Q&A: NCPA Announces Independent Community Pharmacy Consortium for Government Engagement
January 21st 2025Kurt Proctor, BS Pharm, PhD, CCHS, President of the NCPA Innovation Center, discussed his organization’s efforts in launching the Independent Community Pharmacy Consortium for Government Engagement.